Xpeng
XPEV

Xpeng (XPEV) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
BarclaysMaintainedUnderweight$14.00 from $15.00Aug 26, 2026
JP MorganMaintainedOverweight$24.00 from $27.00Aug 25, 2026
BarclaysMaintainedUnderweight$15.00 from $16.00Jul 16, 2026
MacquarieUpgradedNeutral → Outperform$19.00May 29, 2026
BarclaysMaintainedUnderweight$16.00 from $17.00Mar 24, 2026
MacquarieDowngradedOutperform → Neutral$19.00 from $24.00Mar 23, 2026
Freedom Capital MarketsUpgradedHold → Buy$25.00 from $20.00Jan 6, 2026
CitigroupMaintainedBuy$29.40 from $29.00Aug 20, 2025
B of A SecuritiesMaintainedBuy$26.00 from $25.00Aug 19, 2025
MacquarieMaintainedOutperform$25.00 from $24.00Aug 15, 2025
MacquarieUpgradedNeutral → Outperform$24.00May 22, 2025
BarclaysMaintainedUnderweight$20.00 from $7.00Mar 20, 2025
B of A SecuritiesMaintainedBuy$27.00 from $18.60Mar 19, 2025
JP MorganMaintainedOverweight$31.00 from $35.00Mar 19, 2025
CitigroupUpgradedNeutral → Buy$29.00 from $13.70Mar 10, 2025
UBSUpgradedSell → Neutral$18.00 from $8.80Feb 24, 2025
MacquarieDowngradedOutperform → Neutral$18.00Feb 7, 2025
UBSDowngradedNeutral → Sell$8.80 from $8.20Dec 5, 2024
China RenaissanceUpgradedHold → Buy$16.70Nov 22, 2024
BernsteinMaintainedMarket Perform$14.00 from $9.00Nov 20, 2024

Frequently asked questions

  • What is the latest analyst rating on XPEV?

    On Aug 26, 2026, Barclays maintained Xpeng at Underweight with a price target of $14.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.